Viome Stock
Discovering predictive biomarkers to eradicate all diseases.
Sign up today and learn more about Viome Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Viome Stock
Viome is a team of leading entrepreneurs, scientists, and physicians. Their proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory. Viome’s pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data they receive. As the sample size grows, their machines will spot trends and influences, which will unlock scientific breakthroughs.
Funding History
July 2017 | $15.0M |
---|
Management
Founder & President
Deepak Savadatti
Founder & CEO
Naveen Jain
Chief Medical Officer
Helen Messier
Press
forbes - Apr, 9 2024
Viome Gut Intelligence Test Review (2024) – Forbes Healthprnewswire - Apr, 9 2024
Viome Is Partnering with Henry Schein to Provide Better Access to Oral Health Pro™ With CancerDetect™marketscreener - Apr, 2 2024
Viome Is Partnering with Henry Schein, Inc. to Provide Better Access to Oral Health Pro with Cancerdetectbizjournals - Dec, 20 2023
Impel Pharmaceuticals CEO Adrian Adams steps down ...geekwire - Dec, 20 2023
Seattle startup raises $1.3M to help Amazon sellers manage ...